Analyst Ratings for Repligen Corp. (RGEN)

Updated: 2017-07-27

Shares of Repligen Corp. (NASDAQ:RGEN) have received a consensus rating of Overweight from Wall Street analysts. RGEN had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 4 analysts, 0 issued an overweight rating, 2 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

RGEN was given price targets by several analysts. The highest price target was 50, implying potential capital gains of 22.79 percent. The lowest price target was 40, implying a possible loss of -1.77 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is -11.76 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.82 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 2 analysts made negative revisions to their fiscal year's estimates.

The growth rate of RGEN's earnings is estimated by analysts to be 43.7 percent. The PEG ratio of a stock is another value frequently studied by investors. Smaller PEG ratios are desirable, because people typically see that as an indicator of higher growth relative to stock price. PEG ratios below 1 are often considered desirable, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of RGEN is 2.45.

RGEN has a 52-week high of 46.81 and a 52-week low of 26.16. Currently the stock is 55.66 percent higher than its low, and 13.01 percent below the high. RGEN has a price/earnings ratio of 107.16. Investors typically compare the P/E ratio to a company's peers in the industry. The RGEN value stock report compares RGEN to some of its peers using value stock charts. The stock has a market capitalization of $1.54 billion. RGEN will post this quarters earnings in days, on 0000-00-00.